These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 9029066)
1. Muscle-eye-brain disease: a neuropathological study. Haltia M; Leivo I; Somer H; Pihko H; Paetau A; Kivelä T; Tarkkanen A; Tomé F; Engvall E; Santavuori P Ann Neurol; 1997 Feb; 41(2):173-80. PubMed ID: 9029066 [TBL] [Abstract][Full Text] [Related]
2. Cobblestone lissencephaly with normal eyes and muscle. Dobyns WB; Patton MA; Stratton RF; Mastrobattista JM; Blanton SH; Northrup H Neuropediatrics; 1996 Apr; 27(2):70-5. PubMed ID: 8737821 [TBL] [Abstract][Full Text] [Related]
3. Phenotypic spectrum of Fukutinopathy: most severe phenotype of Fukutinopathy. Yoshioka M Brain Dev; 2009 Jun; 31(6):419-22. PubMed ID: 18834683 [TBL] [Abstract][Full Text] [Related]
4. Expression and localization of fukutin, POMGnT1, and POMT1 in the central nervous system: consideration for functions of fukutin. Yamamoto T; Kato Y; Kawaguchi M; Shibata N; Kobayashi M Med Electron Microsc; 2004 Dec; 37(4):200-7. PubMed ID: 15614444 [TBL] [Abstract][Full Text] [Related]
5. Genetic identity of Fukuyama-type congenital muscular dystrophy and Walker-Warburg syndrome. Toda T; Yoshioka M; Nakahori Y; Kanazawa I; Nakamura Y; Nakagome Y Ann Neurol; 1995 Jan; 37(1):99-101. PubMed ID: 7818265 [TBL] [Abstract][Full Text] [Related]
6. Clinical and genetic distinction between Walker-Warburg syndrome and muscle-eye-brain disease. Cormand B; Pihko H; Bayés M; Valanne L; Santavuori P; Talim B; Gershoni-Baruch R; Ahmad A; van Bokhoven H; Brunner HG; Voit T; Topaloglu H; Dobyns WB; Lehesjoki AE Neurology; 2001 Apr; 56(8):1059-69. PubMed ID: 11320179 [TBL] [Abstract][Full Text] [Related]
7. Fukuyama-type congenital muscular dystrophy and the Walker-Warburg syndrome. Kimura S; Sasaki Y; Kobayashi T; Ohtsuki N; Tanaka Y; Hara M; Miyake S; Yamada M; Iwamoto H; Misugi N Brain Dev; 1993; 15(3):182-91. PubMed ID: 8214343 [TBL] [Abstract][Full Text] [Related]
8. Glycosylation defects: a new mechanism for muscular dystrophy? Grewal PK; Hewitt JE Hum Mol Genet; 2003 Oct; 12 Spec No 2():R259-64. PubMed ID: 12925572 [TBL] [Abstract][Full Text] [Related]
9. Ocular manifestations in Fukuyama type congenital muscular dystrophy. Yoshioka M; Kuroki S; Kondo T Brain Dev; 1990; 12(4):423-6. PubMed ID: 2240463 [TBL] [Abstract][Full Text] [Related]
10. [Alpha-dystroglycanopathy (FCMD, MEB, etc): abnormal glycosylation and muscular dystrophy]. Toda T Rinsho Shinkeigaku; 2005 Nov; 45(11):932-4. PubMed ID: 16447766 [TBL] [Abstract][Full Text] [Related]
11. Severe muscle-eye-brain disease is associated with a homozygous mutation in the POMGnT1 gene. Teber S; Sezer T; Kafali M; Manzini MC; Konuk Yüksel B; Tekin M; Fitöz S; Walsh CA; Deda G Eur J Paediatr Neurol; 2008 Mar; 12(2):133-6. PubMed ID: 17881266 [TBL] [Abstract][Full Text] [Related]
12. [Fukuyama-type congenital muscular dystrophy with the presence of ocular anomalies]. Castellacci AM; Gualtierotti R; Santillo G; Simoni F; Pieroni O; Pazzaglia R Pediatr Med Chir; 1992; 14(2):223-6. PubMed ID: 1508760 [TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance imaging in classification of congenital muscular dystrophies with brain abnormalities. van der Knaap MS; Smit LM; Barth PG; Catsman-Berrevoets CE; Brouwer OF; Begeer JH; de Coo IF; Valk J Ann Neurol; 1997 Jul; 42(1):50-9. PubMed ID: 9225685 [TBL] [Abstract][Full Text] [Related]
14. Clinical spectrum and genetic studies of Fukuyama congenital muscular dystrophy. Yoshioka M; Kuroki S Am J Med Genet; 1994 Nov; 53(3):245-50. PubMed ID: 7856660 [TBL] [Abstract][Full Text] [Related]
15. Neuropathological findings in muscle-eye-brain disease (MEB-D). Neuropathological delineation of MEB-D from congenital muscular dystrophy of the Fukuyama type. Leyten QH; Renkawek K; Renier WO; Gabreëls FJ; Mooy CM; ter Laak HJ; Mullaart RA Acta Neuropathol; 1991; 83(1):55-60. PubMed ID: 1792864 [TBL] [Abstract][Full Text] [Related]
17. POMT2 mutations cause alpha-dystroglycan hypoglycosylation and Walker-Warburg syndrome. van Reeuwijk J; Janssen M; van den Elzen C; Beltran-Valero de Bernabé D; Sabatelli P; Merlini L; Boon M; Scheffer H; Brockington M; Muntoni F; Huynen MA; Verrips A; Walsh CA; Barth PG; Brunner HG; van Bokhoven H J Med Genet; 2005 Dec; 42(12):907-12. PubMed ID: 15894594 [TBL] [Abstract][Full Text] [Related]
18. Worldwide distribution and broader clinical spectrum of muscle-eye-brain disease. Taniguchi K; Kobayashi K; Saito K; Yamanouchi H; Ohnuma A; Hayashi YK; Manya H; Jin DK; Lee M; Parano E; Falsaperla R; Pavone P; Van Coster R; Talim B; Steinbrecher A; Straub V; Nishino I; Topaloglu H; Voit T; Endo T; Toda T Hum Mol Genet; 2003 Mar; 12(5):527-34. PubMed ID: 12588800 [TBL] [Abstract][Full Text] [Related]
19. [Merosin-positive congenital muscular dystrophy, white matter abnormalities, and bilateral posterior occipital cortical dysplasia]. Ribeiro VT; Moreira NC; Teixeira J; Guimarães A; Cruz R; Lima L Acta Med Port; 2003; 16(3):189-92. PubMed ID: 12868400 [TBL] [Abstract][Full Text] [Related]